• Conference Proceeding

Clinically meaningful change benchmarks for IBS-C symptoms developed using data from two phase 3 trials of linaclotide

Citation

Spiegel, B. M., Locke, G., Kurtz, C. M., Williams, V. S., Nelson, L. M., Carson, R. T., ... Johnston, J. M. (2012). Clinically meaningful change benchmarks for IBS-C symptoms developed using data from two phase 3 trials of linaclotide. In [24], pp. 35–35. .

Abstract